arrow
N

Naoto Gotohda

National Cancer Center Hospital East
H指数:41
被引数:5,868

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Clinicopathological Characteristics and Prognosis of Cholangiolocarcinoma: A Multicenter Study With a Central Pathology Review

胆管细胞癌的临床病理特征与预后:一项包含中央病理学审查的多中心研究

2026-09-200
OAAI
T-cell receptor–engineered T-cell therapy using a glypican-3–specific TCR derived from a hepatoblastoma vaccine responder for HLA-A2–positive glypican-3–expressing cancers

使用源自肝母细胞瘤疫苗应答者的糖蛋白-3特异性TCR进行T细胞受体工程化T细胞疗法,以治疗HLA-A2阳性糖蛋白-3表达型癌症

2026-06-260
OAAI
Utility of the Iwate Difficulty Scoring System for the Stratification of Laparoscopic Right Hepatectomies: An International Multicenter Study

岩手困难评分系统在腹腔镜右半肝切除术分层中的应用:一项国际多中心研究

2026-05-010
PRE
Laparoscopic versus open liver resection in patients aged at least 80 years: retrospective propensity score-matched cohort study

腹腔镜与开腹肝切除术在年龄至少80岁患者中的比较:回顾性倾向性评分匹配队列研究

2025-12-010
OAAI
Response to Chemotherapy as a Key Factor in Time to Surgical Failure Following Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases: A Retrospective Cohort Study

化疗反应作为影响初始不可切除结直肠癌肝转移行转化肝切除术后手术失败时间的关键因素:一项回顾性队列研究

2025-11-280
PRE
Prognostic stratification of recurrent colorectal liver metastasis: impact of recurrence-free interval, tumor numbers, and size on repeat liver resection

复发性结直肠癌肝转移的预后分层:无复发生存期、肿瘤数量及大小对再次肝切除的影响

2025-11-210
PRE
Survival Outcomes of Patients with BRAF V600E-Mutant Resectable Extrahepatic Colorectal Oligometastases After Upfront Metastasectomy

BRAF V600E突变可切除性肝外结直肠癌寡转移患者行 upfront metastasectomy 术后的生存结局

2025-09-220
PRE
Patients With Pancreatic Cancer With Synchronous Liver Oligometastasis Show a Significant Long-Term Survival Benefit From Resection Under Specific Conditions: A Multicenter National Cohort Study

同步性肝寡转移的胰腺癌患者在接受特定条件下的切除术后显示出显著的长生存获益:一项多中心国家队列研究

2025-07-130
OAAI
Factors Affecting Nonfunctioning Small Pancreatic Neuroendocrine Neoplasms and Proposed New Treatment Strategies
2024-07-012
OAAI
A multi-institutional randomized phase III study comparing minimally invasive distal pancreatectomy versus open distal pancreatectomy for pancreatic cancer; Japan Clinical Oncology Group study JCOG2202 (LAPAN study)
2024-02-192
OAAI
Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202
EJSO
IF2.9
2024-02-012
PRE